Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CTMX
MNPR
Add up to 3 more stocks
CTMX
CytomX Therapeutics, Inc.
-0.78%
$2.56-0.02Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$557.32M
52W Range
$2.48 - $8.21
MNPR
Monopar Therapeutics Inc.
+1.63%
$79.57+1.28Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$533.04M
52W Range
$50.07 - $124.82
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.85 | 4.07 |
| P/S Ratio | 30.45 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 98.6% | 0.0% |
| Operating Margin | -29.4% | 0.0% |
| Net Margin | -435.2% | 0.0% |
| ROE | -26.4% | -13.6% |
| ROA | -20.9% | -13.2% |
| ROIC | -25.4% | -16.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.36 | 33.56 |
| Quick Ratio | 9.36 | 33.56 |
| Debt/Equity | 0.02 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.